94 related articles for article (PubMed ID: 24671499)
1. No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan.
Huang WK; Chiou MJ; Kuo CF; Lin YC; Yu KH; See LC
Rheumatol Int; 2014 Oct; 34(10):1379-86. PubMed ID: 24671499
[TBL] [Abstract][Full Text] [Related]
2. Hypothyroidism risk associated with rheumatoid arthritis: A population-based retrospective cohort study.
Huang CM; Sung FC; Chen HJ; Lin CC; Lin CL; Huang PH
Medicine (Baltimore); 2022 Jan; 101(1):e28487. PubMed ID: 35029902
[TBL] [Abstract][Full Text] [Related]
3. Severity of Complications and Duration of Type 2 Diabetes and the Risk of Cancer: A Population-Based Study.
Hu YW; Yeh CM; Liu CJ; Chen TJ; Huang N; Chou YJ
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):739-748. PubMed ID: 38412010
[TBL] [Abstract][Full Text] [Related]
4. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population.
Hashimoto A; Chiba N; Tsuno H; Komiya A; Furukawa H; Matsui T; Nishino J; Tohma S
J Rheumatol; 2015 Apr; 42(4):564-71. PubMed ID: 25593236
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study.
Chang SH; Park JK; Lee YJ; Yang JA; Lee EY; Song YW; Lee EB
Arthritis Res Ther; 2014 Aug; 16(4):428. PubMed ID: 25163486
[TBL] [Abstract][Full Text] [Related]
6. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis.
Simon TA; Thompson A; Gandhi KK; Hochberg MC; Suissa S
Arthritis Res Ther; 2015 Aug; 17(1):212. PubMed ID: 26271620
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization: genetic anchors for causal inference in epidemiological studies.
Davey Smith G; Hemani G
Hum Mol Genet; 2014 Sep; 23(R1):R89-98. PubMed ID: 25064373
[TBL] [Abstract][Full Text] [Related]
8. The genetic liability to rheumatoid arthritis may decrease hepatocellular carcinoma risk in East Asian population: a Mendelian randomization study.
Zhang Y; Zhang Y; He P; Ge F; Huo Z; Qiao G
Arthritis Res Ther; 2023 Mar; 25(1):49. PubMed ID: 36973792
[TBL] [Abstract][Full Text] [Related]
9. Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice.
Huss V; Bower H; Wadström H; Frisell T; Askling J;
Rheumatology (Oxford); 2022 May; 61(5):1810-1818. PubMed ID: 34324640
[TBL] [Abstract][Full Text] [Related]
10. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.
Davies NM; Holmes MV; Davey Smith G
BMJ; 2018 Jul; 362():k601. PubMed ID: 30002074
[TBL] [Abstract][Full Text] [Related]
11. The MR-Base platform supports systematic causal inference across the human phenome.
Hemani G; Zheng J; Elsworth B; Wade KH; Haberland V; Baird D; Laurin C; Burgess S; Bowden J; Langdon R; Tan VY; Yarmolinsky J; Shihab HA; Timpson NJ; Evans DM; Relton C; Martin RM; Davey Smith G; Gaunt TR; Haycock PC
Elife; 2018 May; 7():. PubMed ID: 29846171
[TBL] [Abstract][Full Text] [Related]
12. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.
Verbanck M; Chen CY; Neale B; Do R
Nat Genet; 2018 May; 50(5):693-698. PubMed ID: 29686387
[TBL] [Abstract][Full Text] [Related]
13. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.
Bowden J; Davey Smith G; Burgess S
Int J Epidemiol; 2015 Apr; 44(2):512-25. PubMed ID: 26050253
[TBL] [Abstract][Full Text] [Related]
14. Causal Effects between Gut Microbiome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Two-Sample Mendelian Randomization Study.
He G; Cao Y; Ma H; Guo S; Xu W; Wang D; Chen Y; Wang H
Front Microbiol; 2023; 14():1190894. PubMed ID: 37485509
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory factors and risk of meningiomas: a bidirectional mendelian-randomization study.
Zhang Z; Wang S; Ren F; Yang L; Xie H; Pan L; Li Y; Yu B; Yang Y; Su H; Chen Y; Zhang C; Chen H; Yang W; An N; Bai Y
Front Neurosci; 2023; 17():1186312. PubMed ID: 37425011
[TBL] [Abstract][Full Text] [Related]
16. The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study.
Choi B; Park HJ; Song YK; Oh YJ; Kim IW; Oh JM
Arthritis Res Ther; 2022 Aug; 24(1):191. PubMed ID: 35945635
[TBL] [Abstract][Full Text] [Related]
17. Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort.
Sugimoto N; Tanaka E; Inoue E; Abe M; Sugano E; Sugitani N; Saka K; Ochiai M; Higuchi Y; Yamaguchi R; Ikari K; Nakajima A; Yamanaka H; Harigai M
Mod Rheumatol; 2023 Jul; 33(4):715-722. PubMed ID: 35920098
[TBL] [Abstract][Full Text] [Related]
18. Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors.
Wadström H; Pettersson A; Smedby KE; Askling J
Ann Rheum Dis; 2020 May; 79(5):581-586. PubMed ID: 32161056
[TBL] [Abstract][Full Text] [Related]
19. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.
Sepriano A; Kerschbaumer A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JW; Burmester GR; de Wit M; Falzon L; Landewé R
Ann Rheum Dis; 2020 Jun; 79(6):760-770. PubMed ID: 32033941
[TBL] [Abstract][Full Text] [Related]
20. Allergic disease, corticosteroid use, and risk of Hodgkin lymphoma: A United Kingdom nationwide case-control study.
Rafiq M; Hayward A; Warren-Gash C; Denaxas S; Gonzalez-Izquierdo A; Lyratzopoulos G; Thomas S
J Allergy Clin Immunol; 2020 Mar; 145(3):868-876. PubMed ID: 31730878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
